Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
Prostate Cancer and Prostatic Diseases, Published online: 04 March 2021; doi:10.1038/s41391-021-00335-2Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 4, 2021 Category: Urology & Nephrology Authors: Ning wang Yangtian Ye Minhua Deng Diwei Zhao Lijuan Jiang Dong Chen Zhiming Wu Yanjun Wang ZhiYong Li Zhenyu Yang Jibin Li Fangjian Zhou Yonghong Li Source Type: research

Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios
Prostate Cancer and Prostatic Diseases, Published online: 02 March 2021; doi:10.1038/s41391-021-00320-9Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 2, 2021 Category: Urology & Nephrology Authors: Karen Chiam Chelsea Carle Suzanne Hughes James G. Kench Henry H. Woo Sally Lord David P. Smith Source Type: research

Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Prostate Cancer and Prostatic Diseases, Published online: 21 February 2021; doi:10.1038/s41391-021-00318-3Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 21, 2021 Category: Urology & Nephrology Authors: Scott T. Tagawa Krishnan Ramaswamy Ahong Huang Jack Mardekian Neil M. Schultz Li Wang Rickard Sandin Stanislav Lechpammer Daniel J. George Source Type: research

Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
Prostate Cancer and Prostatic Diseases, Published online: 18 February 2021; doi:10.1038/s41391-021-00336-1Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 18, 2021 Category: Urology & Nephrology Authors: Rosario F. Di Stefano Marcello Tucci Fabio Turco Alessandro Samuelly Maristella Bungaro Chiara Pisano Francesca Vignani Mara Gallicchio Giorgio V. Scagliotti Massimo Di Maio Consuelo Buttigliero Source Type: research

Treating the patient and not just the cancer: therapeutic burden in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 18 February 2021; doi:10.1038/s41391-021-00328-1Treating the patient and not just the cancer: therapeutic burden in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 18, 2021 Category: Urology & Nephrology Authors: Daniel E. Spratt Neal Shore Oliver Sartor Dana Rathkopf Kara Olivier Source Type: research

PSA response to antiandrogen withdrawal: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 18 February 2021; doi:10.1038/s41391-021-00337-0PSA response to antiandrogen withdrawal: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 18, 2021 Category: Urology & Nephrology Authors: Alwin Soo Michael E. O ’Callaghan Tina Kopsaftis Sina Vatandoust Kim Moretti Ganessan Kichenadasse Source Type: research

Clinical significance of STEAP1 extracellular vesicles in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 15 February 2021; doi:10.1038/s41391-021-00319-2Clinical significance of STEAP1 extracellular vesicles in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 15, 2021 Category: Urology & Nephrology Authors: Karan Khanna Nikki Salmond Kalan S. Lynn Hon S. Leong Karla C. Williams Source Type: research

Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 15 February 2021; doi:10.1038/s41391-021-00329-0Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 15, 2021 Category: Urology & Nephrology Authors: Fumihiko Urabe Shoji Kimura Shutaro Yamamoto Kojiro Tashiro Takahiro Kimura Shin Egawa Source Type: research

Patient- and tumor-level risk factors for MRI-invisible prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 10 February 2021; doi:10.1038/s41391-021-00330-7Patient- and tumor-level risk factors for MRI-invisible prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 10, 2021 Category: Urology & Nephrology Authors: Paige K. Kuhlmann Michelle Chen Michael Luu Aurash Naser-Tavakolian Devin N. Patel Hyung L. Kim Rola Saouaf Timothy J. Daskivich Source Type: research

Clinical considerations for the management of androgen indifferent prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 10 February 2021; doi:10.1038/s41391-021-00332-5Clinical considerations for the management of androgen indifferent prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 10, 2021 Category: Urology & Nephrology Authors: Jacob E. Berchuck Paul V. Viscuse Himisha Beltran Ana Aparicio Source Type: research

Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 10 February 2021; doi:10.1038/s41391-021-00324-5Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 10, 2021 Category: Urology & Nephrology Authors: Andrew J. Armstrong Xiaotong Li Matthew Tucker Shantao Li Xinmeng Jasmine Mu Kenneth Wha Eng Andrea Sboner Mark Rubin Mark Gerstein Source Type: research

ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development
Prostate Cancer and Prostatic Diseases, Published online: 10 February 2021; doi:10.1038/s41391-021-00322-7ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 10, 2021 Category: Urology & Nephrology Authors: Haiqing He Jun Hao Xin Dong Yu Wang Hui Xue Sifeng Qu Stephen Yiu Chuen Choi Xinpei Ci Yong Wang Rebecca Wu Mingchen Shi Xiaokun Zhao Colin Collins Dong Lin Yuzhuo Wang Source Type: research

Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-021-00323-6Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Saurabh Singh Caroline M. Moore Shonit Punwani Anita V. Mitra Steve Bandula Source Type: research

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-020-00310-3Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Fred Saad Martin B ögemann Kazuhiro Suzuki Neal Shore Source Type: research

Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-021-00327-2Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Daniel A. Galv ão Robert U. Newton Suzanne K. Chambers Nigel Spry David Joseph Robert A. Gardiner Ciaran M. Fairman Dennis R. Taaffe Source Type: research

Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-021-00321-8Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Al Baha Barqawi Rodrigo Rodrigues Pessoa E. David Crawford Mohammed Al-Musawi Tracey MacDermott Colin O ’Donell Ross M. Kendl Source Type: research

Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-020-00313-0Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Francesca Kum Kerri Beckmann Haleema Aya Sohail Singh Preeti Sandhu Sukhmani Sra Jonah Rusere Grace Zisengwe Aida Santaolalla Paul Cathcart Ben Challacombe Christian Brown Rick Popert Prokar Dasgupta Mieke Van Hemelrijck Oussama Elhage Source Type: research

Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-021-00331-6Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Gulanbar Amori Emiko Sugawara Yasuyuki Shigematsu Masashi Akiya Junko Kunieda Takeshi Yuasa Shinya Yamamoto Junji Yonese Kengo Takeuchi Kentaro Inamura Source Type: research

Prostate biopsy and fiducial placement in the same sitting- a good option during COVID pandemic as well as in patients on anticoagulants/antiplatelets
Prostate Cancer and Prostatic Diseases, Published online: 08 February 2021; doi:10.1038/s41391-021-00333-4Prostate biopsy and fiducial placement in the same sitting- a good option during COVID pandemic as well as in patients on anticoagulants/antiplatelets (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 8, 2021 Category: Urology & Nephrology Authors: Anitha Sen Aswin Kumar Jubie Raj Source Type: research

Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data
Prostate Cancer and Prostatic Diseases, Published online: 02 February 2021; doi:10.1038/s41391-021-00326-3Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2021 Category: Urology & Nephrology Authors: Alberto Martini Anish B. Parikh John P. Sfakianos Francesco Montorsi Matthew D. Galsky William K. Oh Che-Kai Tsao Source Type: research

A comparative study of PCS and PAM50 prostate cancer classification schemes
Prostate Cancer and Prostatic Diseases, Published online: 02 February 2021; doi:10.1038/s41391-021-00325-4A comparative study of PCS and PAM50 prostate cancer classification schemes (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2021 Category: Urology & Nephrology Authors: Junhee Yoon Minhyung Kim Edwin M. Posadas Stephen J. Freedland Yang Liu Elai Davicioni Robert B. Den Bruce J. Trock R. Jeffrey Karnes Eric A. Klein Michael R. Freeman Sungyong You Source Type: research

Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study
Prostate Cancer and Prostatic Diseases, Published online: 28 January 2021; doi:10.1038/s41391-020-00315-yFocal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2021 Category: Urology & Nephrology Authors: Taimur T. Shah Deepika Reddy Max Peters Daniel Ball Na Hyun Kim Enrique Gomez Gomez Saiful Miah David Eldred Evans Stephanie Guillaumier Peter S. N. van Rossum Marieke J. Van Son Feargus Hosking-Jervis Tim Dudderidge Richard Hindley Amr Emara Stuart McCra Source Type: research

Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide
Prostate Cancer and Prostatic Diseases, Published online: 26 January 2021; doi:10.1038/s41391-020-00309-wAndrogen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 26, 2021 Category: Urology & Nephrology Authors: M. Del Re V. Conteduca S. Crucitta G. Gurioli C. Casadei G. Restante G. Schepisi C. Lolli F. Cucchiara R. Danesi U. De Giorgi Source Type: research

Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 25 January 2021; doi:10.1038/s41391-020-00317-wBody composition, physical function and quality of life in healthy men and across different stages of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 25, 2021 Category: Urology & Nephrology Authors: Erik D. Hanson Cameron K. Stopforth Mohamdod Alzer Jackson Carver Alexander R. Lucas Young E. Whang Matthew I. Milowsky David B. Bartlett Michael R. Harrison Alan Hayes Rhonda L. Bitting Allison M. Deal A. C. Hackney Claudio L. Battaglini Source Type: research

Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?
Prostate Cancer and Prostatic Diseases, Published online: 22 January 2021; doi:10.1038/s41391-020-00306-zDoes prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 22, 2021 Category: Urology & Nephrology Authors: Ahmed ElShafei Molly DeWitt-Foy Adam Calaway Austin J. Fernstrum Adonis Hijaz Wade Muncey Anood Alfahmy Amr Mahran Kirtishri Mishra J. Stephen Jones Thomas J. Polascik Source Type: research

Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England
Prostate Cancer and Prostatic Diseases, Published online: 21 January 2021; doi:10.1038/s41391-020-00316-xOverall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 21, 2021 Category: Urology & Nephrology Authors: Kenrick Ng Peter Wilson Katherine Mutsvangwa Luke Hounsome Jonathan Shamash Source Type: research

Clinical implications of genomic alterations in metastatic prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 15 January 2021; doi:10.1038/s41391-020-00308-xClinical implications of genomic alterations in metastatic prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 15, 2021 Category: Urology & Nephrology Authors: Takayuki Sumiyoshi Kim N. Chi Alexander W. Wyatt Source Type: research

Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions
Prostate Cancer and Prostatic Diseases, Published online: 08 January 2021; doi:10.1038/s41391-020-00314-zEarly-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 8, 2021 Category: Urology & Nephrology Authors: Zachary R. Chalmers Michael C. Burns Ericka M. Ebot Garrett M. Frampton Jeffrey S. Ross Maha H. A. Hussain Sarki A. Abdulkadir Source Type: research

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 08 January 2021; doi:10.1038/s41391-020-00311-2Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 8, 2021 Category: Urology & Nephrology Authors: Roshan A. Karunamuni Minh-Phuong Huynh-Le Chun C. Fan Wesley Thompson Rosalind A. Eeles Zsofia Kote-Jarai Kenneth Muir Artitaya Lophatananon Johanna Schleutker Nora Pashayan Jyotsna Batra Henrik Gr önberg Eleanor I. Walsh Emma L. Turner Athene Lane Richa Source Type: research

Urine spermine and multivariable Spermine Risk Score predict high-grade prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 06 January 2021; doi:10.1038/s41391-020-00312-1Urine spermine and multivariable Spermine Risk Score predict high-grade prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 6, 2021 Category: Urology & Nephrology Authors: Peter Ka-Fung Chiu Yan-Ho Fung Jeremy Yuen-Chun Teoh Chun-Hong Chan Ka-Lun Lo Kai-Man Li Ryan Tsz-Hei Tse Chi-Ho Leung Yim-Ping Wong Monique J. Roobol Ka-Leung Wong Chi-Fai Ng Source Type: research

Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience
Prostate Cancer and Prostatic Diseases, Published online: 02 December 2020; doi:10.1038/s41391-020-00307-yOligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 2, 2020 Category: Urology & Nephrology Authors: Luca Boeri Vidit Sharma Eugene Kwon Bradley J. Stish Brian J. Davis R. Jeffrey Karnes Source Type: research

Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 23 November 2020; doi:10.1038/s41391-020-00304-1Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 23, 2020 Category: Urology & Nephrology Authors: Steffi Oeyen Vincent Li égeois Bram De Laere Andy Buys Michiel Strijbos Piet Dirix Paul Meijnders Peter Vermeulen Steven Van Laere Luc Dirix Source Type: research

A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk
Prostate Cancer and Prostatic Diseases, Published online: 20 November 2020; doi:10.1038/s41391-020-00298-wA systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 20, 2020 Category: Urology & Nephrology Authors: E. J. Bass A. Pantovic M. Connor R. Gabe A. R. Padhani A. Rockall H. Sokhi H. Tam M. Winkler H. U. Ahmed Source Type: research

What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes
Prostate Cancer and Prostatic Diseases, Published online: 20 November 2020; doi:10.1038/s41391-020-00301-4What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 20, 2020 Category: Urology & Nephrology Authors: Pedro Lopez Dennis R. Taaffe Robert U. Newton Laurien M. Buffart Daniel A. Galv ão Source Type: research

Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk
Prostate Cancer and Prostatic Diseases, Published online: 20 November 2020; doi:10.1038/s41391-020-00303-2Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 20, 2020 Category: Urology & Nephrology Authors: Weiqiang Li Robert J. Klein Source Type: research

TP53 alterations of hormone-naïve prostate cancer in the Chinese population
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2020; doi:10.1038/s41391-020-00302-3TP53 alterations of hormone-naïve prostate cancer in the Chinese population (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2020 Category: Urology & Nephrology Authors: Zhengfang Liu Hu Guo Yaofeng Zhu Yangyang Xia Jianfeng Cui Kai Shi Yidong Fan Benkang Shi Shouzhen Chen Source Type: research

Stereotactic body radiation therapy use for high risk prostate cancer in the United States
Prostate Cancer and Prostatic Diseases, Published online: 13 November 2020; doi:10.1038/s41391-020-00300-5Stereotactic body radiation therapy use for high risk prostate cancer in the United States (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 13, 2020 Category: Urology & Nephrology Authors: Sagar A. Patel Jeffrey M. Switchenko Amar U. Kishan Ashesh B. Jani Trevor J. Royce Benjamin W. Fischer-Valuck Source Type: research

Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies
Prostate Cancer and Prostatic Diseases, Published online: 09 November 2020; doi:10.1038/s41391-020-00299-9Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2020 Category: Urology & Nephrology Authors: Matthew K. Labriola Saad Atiq Nathan Hirshman Rhonda L. Bitting Source Type: research

Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test
Prostate Cancer and Prostatic Diseases, Published online: 09 November 2020; doi:10.1038/s41391-020-00297-xBiomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2020 Category: Urology & Nephrology Authors: Hari T. Vigneswaran Thorgerdur Palsdottir Henrik Olsson Erik S. Haug Wolfgang Picker Sven L öffeler Henrik Gr önberg Martin Eklund Tobias Nordstr öm Source Type: research

Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0218-2Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2020 Category: Urology & Nephrology Authors: A. Finelli M. Komisarenko L. J. Martin N. Timilshina K. Jain J. Morris A. Zlotta G. Kulkarni N. Perlis T. van der Kwast A. Evans S. Ghai N. Fleshner S. M. H. Alibhai R. J. Hamilton Source Type: research

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0222-6Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2020 Category: Urology & Nephrology Authors: Keiichiro Mori Noriyoshi Miura Hadi Mostafaei Fahad Quhal Reza Sari Motlagh Benjamin Pradere Shoji Kimura Takahiro Kimura Shin Egawa Alberto Briganti Pierre I. Karakiewicz Shahrokh F. Shariat Source Type: research

Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0223-5Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2020 Category: Urology & Nephrology Authors: Connor Hoge Sadhna Verma Daniel J. Lama Ilana Bergelson Monzer Haj-Hamed Sean Maynor Krishnanath Gaitonde Abhinav Sidana Source Type: research

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations
Prostate Cancer and Prostatic Diseases, Published online: 05 March 2020; doi:10.1038/s41391-020-0217-3Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 4, 2020 Category: Urology & Nephrology Authors: Changxue Lu Landon C. Brown Emmanuel S. Antonarakis Andrew J. Armstrong Jun Luo Source Type: research

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 03 March 2020; doi:10.1038/s41391-020-0211-9Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 2, 2020 Category: Urology & Nephrology Authors: Mitchell E. Gross David B. Agus Tanya B. Dorff Jacek K. Pinski David I. Quinn Olga Castellanos Patrick Gilmore Jean C. Shih Source Type: research

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Prostate Cancer and Prostatic Diseases, Published online: 02 March 2020; doi:10.1038/s41391-020-0220-8Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 1, 2020 Category: Urology & Nephrology Authors: Kerri Beckmann Hans Garmo Bertil Lindahl Lars Holmberg P är Stattin Jan Adolfsson J. Kennedy Cruickshank Mieke Van Hemelrijck Source Type: research

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Prostate Cancer and Prostatic Diseases, Published online: 28 February 2020; doi:10.1038/s41391-020-0213-7Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 27, 2020 Category: Urology & Nephrology Authors: Oliver Sartor Andrew J. Armstrong Chiledum Ahaghotu David G. McLeod Matthew R. Cooperberg David F. Penson Philip W. Kantoff Nicholas J. Vogelzang Arif Hussain Christopher M. Pieczonka Neal D. Shore David I. Quinn Eric J. Small Elisabeth I. Heath Ronald F. Source Type: research

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation
Prostate Cancer and Prostatic Diseases, Published online: 24 February 2020; doi:10.1038/s41391-020-0215-5Androgen receptor variant-driven prostate cancer II: advances in clinical investigation (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 23, 2020 Category: Urology & Nephrology Authors: Landon C. Brown Changxue Lu Emmanuel S. Antonarakis Jun Luo Andrew J. Armstrong Source Type: research

Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 24 February 2020; doi:10.1038/s41391-020-0214-6Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 23, 2020 Category: Urology & Nephrology Authors: Sounak Gupta Chad Vanderbilt Wassim Abida Samson W. Fine Satish K. Tickoo Hikmat A. Al-Ahmadie Ying-Bei Chen Sahussapont J. Sirintrapun Kalyani Chadalavada Gouri J. Nanjangud Ann Bialik Michael J. Morris Howard I. Scher Marc Ladanyi Victor E. Reuter Anura Source Type: research

Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 19 February 2020; doi:10.1038/s41391-020-0216-4Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 18, 2020 Category: Urology & Nephrology Authors: M. J. Connor M. Winkler H. U. Ahmed Source Type: research

Copy number alterations are associated with metastatic-lethal progression in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 18 February 2020; doi:10.1038/s41391-020-0212-8Copy number alterations are associated with metastatic-lethal progression in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 17, 2020 Category: Urology & Nephrology Authors: Xiaoyu Wang Catherine S. Grasso Kristina M. Jordahl Suzanne Kolb Yaw A. Nyame Jonathan L. Wright Elaine A. Ostrander Dean A. Troyer Raymond Lance Ziding Feng James Y. Dai Janet L. Stanford Source Type: research